Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma
Maneno muhimu
Kikemikali
Tarehe
Imethibitishwa Mwisho: | 08/31/2011 |
Iliyowasilishwa Kwanza: | 10/09/2011 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 10/16/2011 |
Iliyotumwa Kwanza: | 10/18/2011 |
Sasisho la Mwisho Liliwasilishwa: | 04/02/2012 |
Sasisho la Mwisho Lilichapishwa: | 04/03/2012 |
Tarehe halisi ya kuanza kwa masomo: | 05/31/2011 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 09/30/2011 |
Tarehe ya Kukamilisha Utafiti: | 09/30/2011 |
Hali au ugonjwa
Uingiliaji / matibabu
Procedure: BCC surgery
Other: Tourniquet ischemia
Other: Laser speckle imaging
Awamu
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 18 Years Kwa 18 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - Age ≥ 18 - Histologically proved cutaneous BCC - Patient being informed and having signed the consent to participate to the study Exclusion Criteria: - Counter-indication to surgery - Patient being unable to attend future follow-up visits - Patient with severe cognitive impairment - Patient not affiliated to a social security regimen - Patient with limb BCC and history of peripheral vascular artery surgery like bypass and/or vascular prothesis on the same limb (tourniquet counter-indication) - Local bone invasion of BCC detected with imagery |
Matokeo
Hatua za Matokeo ya Msingi
1. Evaluation of blood perfusion of tumor as ROI (Region Of Interest) [5 months]